Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Biorxiv : the Preprint Server for Biology|March 26, 2024
Overcoming brain-derived therapeutic resistance in HER2+ breast cancer brain metastasisDanyyl Ippolitov, Yi-Han Lin, Jeremy Spence, et al.
Nature Structural & Molecular Biology|January 12, 2018
Structural basis of TRPV5 channel inhibition by econazole revealed by cryo-EMTaylor E T Hughes, David T Lodowski, Kevin W Huynh, et al.
Neuropharmacology|June 21, 2021
A promising chemical series of positive allosteric modulators of the μ-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effectsKerri D Pryce, Hye Jin Kang, Farhana Sakloth, et al.
Cancer Research|February 11, 2025
The Brain-Penetrant Pan-ErbB Inhibitor Poziotinib Effectively Targets HER2+ Breast Cancer Brain MetastasesDanyyl Ippolitov, Yi-Han Lin, Jeremy Spence, et al.
Analytical Chemistry|June 24, 2025
An Integrated Platform for High-Throughput Extraction and Mass Spectrometry-Based Quantification of Cholesterol and SphingosineYi-Han Lin, Yuhong Fang, Maya L Gosztyla, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2024
High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson's diseaseDarian Williams, Logan M Glasstetter, Tiffany T Jong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2021
SOX11 Inhibitors Are Cytotoxic in Mantle Cell LymphomaShashidhar S Jatiani, Stephanie Christie, Violetta V Leshchenko, et al.
Frontiers in Cell and Developmental Biology|December 4, 2023
Phenotype plasticity and altered sensitivity to chemotherapeutic agents in aggressive prostate cancer cellsAllan I Paxson, Loren H Chang, Jaime M C Gard, et al.
Journal of Medicinal Chemistry|February 19, 2026
Structure-Activity Relationship Studies toward the Optimization of First-In-Class Selective Small Molecule Agonists of the GPCR Relaxin/Insulin-like Family Peptide Receptor 2Kenneth J Wilson, Maria Esteban-Lopez, Courtney Myhr, et al.
Pageof 3